Concepedia

T. Rutherford

TR

2

Publications

56

Citations

2

H-Index

2011

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

T. Rutherford is an author at Memorial Sloan Kettering Cancer Center specializing in cancer therapeutics, radiation oncology, and oncology.

Top concepts

Publications per year

2011–2011

2

Publications

2

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC).

C. Aghajanian, N. Finkler, T. Rutherford et al. · Journal of Clinical Oncology · 2011 · 35 citations

, , +21

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC).

C. Aghajanian, N. J. Finkler, T. Rutherford et al. · Journal of Clinical Oncology · 2011 · 21 citations

, , +17

Rows per page

1–2 of 2